Evidence map›Paper›PMID 37185241›Full record

ArticleNature communications2023

miR-483-5p offsets functional and behavioural effects of stress in male mice through synapse-targeted repression of Pgap2 in the basolateral amygdala.

Mariusz Mucha, Anna E Skrzypiec, Jaison B Kolenchery, Valentina Brambilla, Satyam Patel, Alberto Labrador-Ramos, Lucja Kudla, Kathryn Murrall, Nathan Skene, Violetta Dymicka-Piekarska and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. An miRNA with a major impact on stress.Trends in genetics : TIG · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Mariusz Mucha *University of Exeter Medical School, Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK. mwmucha@gmail.com.ORCID 0000-0001-5273-1647
Anna E Skrzypiec *University of Exeter Medical School, Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK.
Jaison B Kolenchery *University of Exeter Medical School, Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK.
Valentina BrambillaUniversity of Exeter Medical School, Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK.
Satyam PatelPharmacy Department, Alberta Health Services, Calgary, AB, Canada.
Alberto Labrador-RamosUniversity of Exeter Medical School, Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK.
Lucja KudlaDepartment of Molecular Neuropharmacology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.
Kathryn MurrallUniversity of Exeter Medical School, Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK.
Nathan SkeneUK Dementia Research Institute at Imperial College London, London, UK.ORCID 0000-0002-6807-3180
Violetta Dymicka-PiekarskaDepartment of Clinical Laboratory Diagnostics, Medical University of Bialystok, Bialystok, Poland.
Agata KlejmanNencki Institute of Experimental Biology, Polish Academy of Sciences, Warszawa, Poland.
Ryszard PrzewlockiDepartment of Molecular Neuropharmacology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.
Valentina MosienkoUniversity of Exeter Medical School, Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK. valentina.mosienko@bristol.ac.uk.ORCID 0000-0002-8562-532X
Robert PawlakUniversity of Exeter Medical School, Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK.
University of Exeter · GBMaj Institute of Pharmacology · PLAlberta Health Services · CAInstytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLMedical University of Białystok · PLUK Dementia Research Institute · GB

Funding

Medical Research Council MR/T031115/1Medical Research Council MR/T04327X/1
6 · The paper itself

Abstract

Severe psychological trauma triggers genetic, biochemical and morphological changes in amygdala neurons, which underpin the development of stress-induced behavioural abnormalities, such as high levels of anxiety. miRNAs are small, non-coding RNA fragments that orchestrate complex neuronal responses by simultaneous transcriptional/translational repression of multiple target genes. Here we show that miR-483-5p in the amygdala of male mice counterbalances the structural, functional and behavioural consequences of stress to promote a reduction in anxiety-like behaviour. Upon stress, miR-483-5p is upregulated in the synaptic compartment of amygdala neurons and directly represses three stress-associated genes: Pgap2, Gpx3 and Macf1. Upregulation of miR-483-5p leads to selective contraction of distal parts of the dendritic arbour and conversion of immature filopodia into mature, mushroom-like dendritic spines. Consistent with its role in reducing the stress response, upregulation of miR-483-5p in the basolateral amygdala produces a reduction in anxiety-like behaviour. Stress-induced neuromorphological and behavioural effects of miR-483-5p can be recapitulated by shRNA mediated suppression of Pgap2 and prevented by simultaneous overexpression of miR-483-5p-resistant Pgap2. Our results demonstrate that miR-483-5p is sufficient to confer a reduction in anxiety-like behaviour and point to miR-483-5p-mediated repression of Pgap2 as a critical cellular event offsetting the functional and behavioural consequences of psychological stress.

Indexed as

Basolateral Nuclear ComplexMicroRNAsAmygdalaAnimalsMaleMembrane GlycoproteinsMiceMicrofilament ProteinsNeuronsSynapsesMacf1 protein, mouseMembrane GlycoproteinsMicrofilament ProteinsMicroRNAsMirn483 microRNA, mousePgap2 protein, mouse

Identifiers

PMID37185241
PMCPMC10130081
OpenAlexW4366986945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.